Here are three of the most recent recalls reported to the FDA in June: Q’Apel Medical recalled its Hippo 072 aspiration system, including the Cheetah delivery tool and aspiration tubing, following a ...

Florida Attorney General James Uthmeier has taken legal action against Contec, a Chinese medical devicemaker, and Miami-based reseller Epsimed, alleging the companies sold patient monitors that pose ...

Hospital labor costs related to drug shortage management have significantly increased, from $359 million in 2019 to $894 million in 2024 — a nearly 150% increase, according to a Vizient report ...

Mark Cuban’s Cost Plus Drug Co. and virtual care provider 9amHealth have partnered to offer obesity medications through a new program targeting self-insured employers. Under the partnership, 9amHealth ...

Anthony Law, MD, PhD, an assistant professor in the department of otolaryngology at Atlanta-based Emory University School of Medicine, has developed an AI model to detect throat cancer in a patient’s ...

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

An Orlando, Fla.-based Advent Health surgeon has performed a prostatectomy via transcontinental robotic telesurgery — the first of an FDA-approved clinical trial to test the technology, according to a ...

The FDA has delayed its decision to approve a new treatment for hereditary angioedema, citing a heavy workload and limited resources. The drug, sebetralstat, developed by Kalvista Pharmaceuticals, was ...

R1 RCM has named Dave Wojczynski president to lead the company’s physician revenue cycle management business. Mr. Wojczynski most recently served as CEO of Revecore, according to a June 18 R1 news ...

Leaders from some of the nation’s largest Catholic health systems — CommonSpirit Health, SSM Health, Avera Health, Christus Health and Covenant Health — are uniting in opposition to Senate Republicans ...

Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,0001 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...

What is your denials management process costing you? Between 2022 and 2023, the cost per management of a denial went up from $43.84 per denial (totaling $19.7 billion in 2022) to $57.23 per denial ...